Vivo Capital ("Vivo" or "the Firm"), a leading global investment firm focused exclusively on healthcare and life sciences, ...

VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). Use of VYKAT XR is contraindicated in patients ...

Google has given a live demonstration of its Android XR-powered smart glasses during the TED2025 conference. Shahram Izadi, the brand’s Android XR lead, demonstrated the glasses’ features including ...

The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for the indication. The approval makes ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In other recent news, Soleno Therapeutics announced the U.S. commercial availability of VYKAT XR, an FDA-approved treatment for hyperphagia in individuals with Prader-Willi syndrome (PWS). This marks ...